ARTA
ASMB icon

A.R.T. Advisors’s Assembly Biosciences ASMB Stock Holding History

A.R.T. Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,260
Closed -$342K – 1300
2018
Q4 		$342K Buy
+1,260
New +$364K 0.02% 881
2018
Q3 		– Sell
-1,238
Closed -$582K – 1389
2018
Q2 		$582K Sell
1,238
-39
-3% -$20.6K 0.02% 861
2018
Q1 		$753K Sell
1,277
-1,800
-58% -$1.12M 0.03% 774
2017
Q4 		$1.67M Buy
+3,077
New +$1.39M 0.07% 431

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

A.R.T. Advisors's ASMB Position: Q1 2019 in Review

A.R.T. Advisors sold out of Assembly Biosciences (ASMB) in Q1 2019, closing a stake of 1,260 shares — an estimated $342K sold.

A.R.T. Advisors first reported a position in ASMB in Q4 2017 and held it in 4 quarters. The position peaked at $1.67M in Q4 2017. 103 funds tracked by Wall St. Rank hold ASMB as of Q1 2019.

  • A.R.T. Advisors reported no remaining Assembly Biosciences position as of Q1 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 1,260 Assembly Biosciences shares in Q1 2019, an estimated $342K.
  • A.R.T. Advisors first reported a position in Assembly Biosciences in Q4 2017 and held it in 4 quarters.
  • A.R.T. Advisors's Assembly Biosciences position peaked at $1.67M in Q4 2017.
  • 103 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.